Veterinary Vaccines & Animal Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] - Global For - MarketsandMarkets

Veterinary Vaccines & Animal Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] - Global For

Veterinary Vaccines & Animal Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] - Global For - MarketsandMarkets
Veterinary Vaccines & Animal Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] - Global For
Published Sep 09, 2013
281 pages — Published Sep 09, 2013
Price US$ 4,650.00  |  Buy this Report Now

About This Report

  
Abstract:



The global animal vaccines market is in its growth phase and is poised to cross the $8 billion mark by 2018. The factors responsible for the growth of the market include increasing incidences of zoonotic diseases in humans; growing prevalence of animal diseases; and increasing investments by government bodies, animal welfare associations, and leading players. Another factor driving the growth in this space is the continuous innovations and introduction of new products in the market. Since 2012, more than 20 new products have been launched, showing the huge potential for growth in this arena. However, increasing maintenance costs for vaccines and the shift towards vegetarian food by consumers will restrict the growth of the market to some extent. With the growing awareness of animal health in emerging economies, new entrants as well as established players have huge opportunities by introducing novel vaccines like DNA and recombinant vaccines and by entering into emerging countries. The global market for animal vaccines is estimated to be worth $5.8 billion by 2013 and is expected to grow at a healthy CAGR of 8.1% to reach $8.6 billion by 2018.

Europe accounts for the largest share of the veterinary vaccines market, followed by North America. Both markets are reaching the maturity phase of growth and will register mid single-digit growth rates for the next five years. Asia, parts of Africa, and LATAM are poised to grow at double-digit rates owing to the increasing investment opportunities for companies in these immature markets and due to the improving healthcare facilities for animals. Countries like China, India, Australia, and Brazil will be major contributors to the growth of the market.

The market is dominated by tier I players and is fairly consolidated with the top 5 players contributing close to 70% of the share. New entrants face high barriers in entering this market as it is a capital-intensive industry with strict regulations.

Scope of the Report

This research report categorizes the global animal vaccines market on the basis of products, animal diseases, and technology. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2011, 2012, and 2013 as well as forecasts up to 2018. Each segment of the market is comprehensively analyzed at a granular level, by geography (Europe, North America, Asia, and the Rest of the World), to provide in-depth information on the global scenario.

The global market is segmented as follows:

By Products:

Livestock vaccines
Porcine vaccines
Poultry vaccines
Companion animal vaccines
Equine vaccines
Aquaculture vaccines
Other veterinery vaccines

By Diseases:

Livestock vaccines
Bovine vaccines
Foot-and-mouth disease
Bovine viral diarrhea
Bovine clostridial diseases
Brucellosis
Infectious bovine rhinotracheitis
Others
Small ruminant veterinary vaccines
Small ruminant clostridial diseases
Scabby mouth infection
Pneumonia and septicemia
Pox diseases
Ovine Johne's disease
Others
Porcine vaccines
Porcine parvovirus
Porcine reproductive respiratory syndrome (PRRS)
Porcine circovirus II
Swine influenza
Swine pneumonia
Others
Poultry vaccines
Infectious bronchitis
Gumboro disease
Avian influenza
Coccidiosis
Marek's disease
Newcastle disease
Others
Companion veterinary vaccines

  
Source:
Document ID
MD 2103
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

Title
Table Of Contents

1 Introduction (Page No. - 22)
1.1 Key Take-Aways
1.2 Report Description
1.3 Research Methodology
1.3.1 Market Size Estimation
1.3.2 Market Share
1.3.3 Key Data Points From Secondary Sources
1.3.4 Key Data Points From Primary Sources
1.3.5 Assumptions
1.4 Markets Covered
1.5 Stakeholders
1.6 Market Scope

2 Executive Summary (Page No. - 33)

3 Market Overview (Page No. - 37)
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Growing Prevalence Of Animal Diseases Will Result In Employing Preventive Measures Like Vaccines
3.3.1.2 Increasing Incidences Of Zoonotic Diseases In Humans Will Propel The Vaccines Market
3.3.1.3 Increasing Investments By Various Government Agencies, Animal Associations, & Leading Players To Propel The Market
3.3.1.4 Continuous Innovations & Introduction Of New Products Propels The Market
3.3.2 Restraints
3.3.2.1 Rising Maintenance Costs For Storage Of Vaccines, A Burden On Manufacturers & Distributors
3.3.2.2 Increasing Adoption Of Vegetarian Food In Major Economies Owing To Increasing Risk Of Obesity And Other Chronic Disorders
3.3.2.3 Persistent Economic Slowdown To Affect Growth
3.3.3 Opportunities
3.3.3.1 Technological Innovations Like Dna Vaccines
3.3.3.2 Growing Awareness Of Animal Health In Emerging Economies
3.3.3.3 Increasing Investment Opportunities In Emerging And Immature Markets
3.4 Regulations For Animal Vaccines
3.4.1 Usda Regulates The Registration Process In U.S.
3.4.2 Emea Is The Apex Body For Approval Of Animal Vaccines In Europe
3.4.3 Maff Regulates The Veterinary Medicinal Products (VMPS) In Japan
3.4.4 Vich Harmonizes The Registration Process In U.S., Europe And Japan
3.5 Porter's Five Forces Analysis
3.5.1 Threat From New Entrants
3.5.2 Threat From Substitutes
3.5.3 Bargaining Power Of Buyers
3.5.4 Bargaining Power Of Suppliers
3.5.5 Competitive Rivalry Among Existing Players
3.6 Market Share Analysis of Animal Vaccines
3.6.1 Global
3.6.2 North America
3.6.3 Europe
3.6.4 Asia

4 Global Market, By Product (Page No. - 58)
4.1 Introduction
4.2 Companion Animal Vaccines
4.2.1 Canine Vaccines Contribute The Largest To The Companion Animal Vaccines Market
4.2.2 Canine
4.2.3 Feline
4.3 Livestock
4.3.1 Increasing Investments By Government Bodies And Companies
4.3.2 Bovine
4.3.3 Small Ruminant
4.4 Poultry
4.5 Porcine
4.6 Equine
4.7 Aquaculture
4.7.1 Aquaculture Vaccines Market To Grow At The Fastest Pace
4.8 Other Animal Vaccines

5 Global Market, By Disease (Page No. - 72)
5.1 Introduction
5.2 Companion Animal Vaccines
5.2.1 Canine Vaccines, By Disease
5.2.1.1 Canine Rabies
5.2.1.2 Canine Distemper
5.2.1.3 Canine Parvovirus
5.2.1.4 Infectious Canine Hepatitis
5.2.2 Feline Vaccines, By Disease
5.2.2.1 Feline Rabies
5.2.2.2 Feline Panleukopenia
5.2.2.3 Feline Viral Rhinotracheitis
5.2.2.4 Feline Leukemia
5.3 Livestock Vaccines
5.3.1 Bovine Vaccines, By Disease
5.3.1.1 Foot And Mouth Disease (FMD)

Table Of Contents

MarketsandMarkets—Worldwide, market research reports primarily sold for numbers, market segmentation and competitive landscape, within the business leaders.

About the Author


Cite this Report

  
MLA:
MarketsandMarkets. "Veterinary Vaccines & Animal Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] - Global For" Sep 09, 2013. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/MarketsandMarkets/Veterinary-Vaccines-Animal-Vaccines-Market-Products-Livestock-Bovine-Companion-Canine-Poultry-Equine-Diseases-Rabies-Distemper-Foot-Mouth-Gumboro-Avian-Influenza-Strangles-Technology-Live-attenuated-DNA-Recombinant-Global-For-2144-385>
  
APA:
MarketsandMarkets. (2013). Veterinary Vaccines & Animal Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] - Global For Sep 09, 2013. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/MarketsandMarkets/Veterinary-Vaccines-Animal-Vaccines-Market-Products-Livestock-Bovine-Companion-Canine-Poultry-Equine-Diseases-Rabies-Distemper-Foot-Mouth-Gumboro-Avian-Influenza-Strangles-Technology-Live-attenuated-DNA-Recombinant-Global-For-2144-385>
  
US$ 4,650.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.